Management of endemic mycoses

2019 ◽  
pp. 317-323
Author(s):  
John R. Perfect ◽  
Ahmad Mourad
Keyword(s):  
Endemic Mycoses

scholarly journals Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017

2018 ◽  
Vol 25 (1) ◽  
Author(s):  
Helmut J F Salzer ◽  
Rhett J Stoney ◽  
Kristina M Angelo ◽  
Thierry Rolling ◽  
Martin P Grobusch ◽  
...  
Keyword(s):  
Endemic Mycoses

Endemic Mycoses in Americas

2019 ◽  
pp. 143-192
Author(s):  
Sandra de Moraes Gimenes Bosco ◽  
Giselle Souza da Paz ◽  
Jéssica Luana Chechi ◽  
Alana Lucena Oliveira ◽  
Ana Carolina do Prado ◽  
...  
Keyword(s):  
Endemic Mycoses

Endemic Mycoses

2016 ◽  
pp. 453-462
Author(s):  
Martin B. Kleiman
Keyword(s):  
Endemic Mycoses

The Diagnosis of Endemic Mycoses

2007 ◽  
pp. 291-354
Author(s):  
John R. Graybill ◽  
Gregory M. Anstead ◽  
Flavio Queiroz-Telles
Keyword(s):  
Endemic Mycoses

scholarly journals Diagnosis of Breakthrough Fungal Infections in the Clinical Mycology Laboratory: An ECMM Consensus Statement

2020 ◽  
Vol 6 (4) ◽  
pp. 216 ◽  
Author(s):  
Jeffrey D. Jenks ◽  
Jean-Pierre Gangneux ◽  
Ilan S. Schwartz ◽  
Ana Alastruey-Izquierdo ◽  
Katrien Lagrou ◽  
...  
Keyword(s):  
Fungal Infections ◽  
Antifungal Susceptibility ◽  
Medical Mycology ◽  
Culture Techniques ◽  
Conventional Culture ◽  
Clinical Mycology ◽  
Diagnostic Modalities ◽  
Antigen Tests ◽  
Endemic Mycoses ◽  
The Impact

Breakthrough invasive fungal infections (bIFI) cause significant morbidity and mortality. Their diagnosis can be challenging due to reduced sensitivity to conventional culture techniques, serologic tests, and PCR-based assays in patients undergoing antifungal therapy, and their diagnosis can be delayed contributing to poor patient outcomes. In this review, we provide consensus recommendations on behalf of the European Confederation for Medical Mycology (ECMM) for the diagnosis of bIFI caused by invasive yeasts, molds, and endemic mycoses, to guide diagnostic efforts in patients receiving antifungals and support the design of future clinical trials in the field of clinical mycology. The cornerstone of lab-based diagnosis of breakthrough infections for yeast and endemic mycoses remain conventional culture, to accurately identify the causative pathogen and allow for antifungal susceptibility testing. The impact of non-culture-based methods are not well-studied for the definite diagnosis of breakthrough invasive yeast infections. Non-culture-based methods have an important role for the diagnosis of breakthrough invasive mold infections, in particular invasive aspergillosis, and a combination of testing involving conventional culture, antigen-based assays, and PCR-based assays should be considered. Multiple diagnostic modalities, including histopathology, culture, antibody, and/or antigen tests and occasionally PCR-based assays may be required to diagnose breakthrough endemic mycoses. A need exists for diagnostic tests that are effective, simple, cheap, and rapid to enable the diagnosis of bIFI in patients taking antifungals.

scholarly journals Endemic mycoses in patients with STAT3-mutated hyper-IgE (Job) syndrome

2015 ◽  
Vol 136 (5) ◽  
pp. 1411-1413.e2 ◽  
Author(s):  
Camila D. Odio ◽  
Ki Lee Milligan ◽  
Katherine McGowan ◽  
Amanda K. Rudman Spergel ◽  
Rachel Bishop ◽  
...  
Keyword(s):  
Endemic Mycoses ◽  
Job Syndrome

scholarly journals Endemic Mycoses in Immunocompromised Hosts

2013 ◽  
Vol 15 (6) ◽  
pp. 536-543 ◽  
Author(s):  
Trent R. Malcolm ◽  
Peter V. Chin-Hong
Keyword(s):  
Endemic Mycoses ◽  
Immunocompromised Hosts

scholarly journals Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease

Respiration ◽  
2018 ◽  
Vol 96 (3) ◽  
pp. 283-301 ◽  
Author(s):  
Helmut J.F. Salzer ◽  
Gerd Burchard ◽  
Oliver A. Cornely ◽  
Christoph Lange ◽  
Thierry Rolling ◽  
...  
Keyword(s):  
Pulmonary Disease ◽  
Diagnosis And Management ◽  
Endemic Mycoses
Sign in / Sign up

Export Citation Format

Share Document